Effects of dexmedetomidine on activity of c-Jun N-terminal kinase during cerebral ischemia-reperfusion in rats
Hongguang Fu
Abstract
Hongguang Fu
Abstract
Objective To evaluate the effects of dexmedetomidine on the activity of c-Jun N-terminal kinase(JNK)during cerebral ischemia-reperfusion(I/R)in rats. Methods Eighty-one pathogen-free male Sprague-Dawley rats, aged 8 weeks, weighing 180-220 g, were randomly divided into 3 groups(n=27 each)using a random number table: sham operation group(group S); cerebral I/R group(group CI/R); dexmedetomidine group(group Dex). The rats were anesthetized with intraperitoneal 10% chloral hydrate 300 mg/kg.Cerebral ischemia was induced by occlusion of the middle cerebral artery for 2 h followed by 24 h of reperfusion in CI/R and Dex groups.The middle cerebral artery was only exposed but not occluded in group S. Dexmedetomidine 3 μg/kg was injected via the tail vein immediately before ischemia followed by infusion at a rate of 3 μg·kg-1·h-1until 24 h of reperfusion in group Dex, while the equal volume of normal saline was given in S and CI/R groups.The rats were sacrificed at 24 h of reperfusion, and their brains were removed for determination of cerebral infarct size(by TTC staining), brain water content((wet weight-dry weight)/wet weight × 100%), cell apoptosis(by TUNEL)and expression of phosphorylated JNK(p-JNK)protein(by Western blot analysis). Apoptotic index was calculated. Results Compared with group S, the brain water content, apoptotic index and cerebral infarct size were significantly increased, and the expression of p-JNK was up-regulated in CI/R and Dex groups.Compared with group CI/R, the brain water content, apoptotic index and cerebral infarct size were significantly decreased, and the expression of p-JNK was down-regulated in group Dex. Conclusion Dexmedetomidine reduces cerebral I/R injury through decreasing the activity of JNK and inhibiting cell apoptosis in rats. Key words: Dexmedetomidine; Reperfusion injury; Brain; JNK mitogen-activated protein kinases
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the effects of dexmedetomidine on the activity of c-Jun N-terminal kinase(JNK)during cerebral ischemia-reperfusion(I/R)in rats. Methods Eighty-one pathogen-free male Sprague-Dawley rats, aged 8 weeks, weighing 180-220 g, were randomly divided into 3 groups(n=27 each)using a random number table: sham operation group(group S); cerebral I/R group(group CI/R); dexmedetomidine group(group Dex). The rats were anesthetized with intraperitoneal 10% chloral hydrate 300 mg/kg.Cerebral ischemia was induced by occlusion of the middle cerebral artery for 2 h followed by 24 h of reperfusion in CI/R and Dex groups.The middle cerebral artery was only exposed but not occluded in group S. Dexmedetomidine 3 μg/kg was injected via the tail vein immediately before ischemia followed by infusion at a rate of 3 μg·kg-1·h-1until 24 h of reperfusion in group Dex, while the equal volume of normal saline was given in S and CI/R groups.The rats were sacrificed at 24 h of reperfusion, and their brains were removed for determination of cerebral infarct size(by TTC staining), brain water content((wet weight-dry weight)/wet weight × 100%), cell apoptosis(by TUNEL)and expression of phosphorylated JNK(p-JNK)protein(by Western blot analysis). Apoptotic index was calculated. Results Compared with group S, the brain water content, apoptotic index and cerebral infarct size were significantly increased, and the expression of p-JNK was up-regulated in CI/R and Dex groups.Compared with group CI/R, the brain water content, apoptotic index and cerebral infarct size were significantly decreased, and the expression of p-JNK was down-regulated in group Dex. Conclusion Dexmedetomidine reduces cerebral I/R injury through decreasing the activity of JNK and inhibiting cell apoptosis in rats. Key words: Dexmedetomidine; Reperfusion injury; Brain; JNK mitogen-activated protein kinases
Key concepts: Dexmedetomidine, Ischemia, Chloral hydrate, Apoptosis, Medicine, Anesthesia, Saline, TUNEL assay